UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The walking dead: macrophage inflammation and death in atherosclerosis

Current opinion in lipidology, 2017-04, Vol.28 (2), p.91-98

2017

Volltextzugriff (PDF)

The Prognostic, Diagnostic, and Therapeutic Potential of TRAIL Signalling in Cardiovascular Diseases

International journal of molecular sciences, 2023-04, Vol.24 (7), p.6725

2023

Volltextzugriff (PDF)

Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2025-2025

2016

Volltextzugriff (PDF)

TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro

Free radical biology & medicine, 2018-10, Vol.126, p.341-349

2018

Volltextzugriff (PDF)

Sex, Endothelial Cell Functions, and Peripheral Artery Disease

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17439

2023

Volltextzugriff (PDF)

TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL

PloS one, 2013-09, Vol.8 (9), p.e74211-e74211

2013

Volltextzugriff (PDF)

Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease

Frontiers in cardiovascular medicine, 2022-11, Vol.9, p.1054576-1054576

2022

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice

Scientific reports, 2017-05, Vol.7 (1), p.1898-12, Article 1898

2017

Volltextzugriff (PDF)

TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice

PloS one, 2014-03, Vol.9 (3), p.e92952-e92952

2014

Volltextzugriff (PDF)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis

Journal of Diabetes Research, 2021, Vol.2021, p.6668506-10

2021

Volltextzugriff (PDF)

Expression, regulation and function of trail in atherosclerosis

Biochemical pharmacology, 2008-04, Vol.75 (7), p.1441-1450

2008

Volltextzugriff (PDF)

Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: Mechanisms of PDGF-BB-mediated VSMC proliferation and migration

Journal of cellular biochemistry, 2012-08, Vol.113 (8), p.2597-2606

2012

Volltextzugriff (PDF)

Regulation and function of Rankl in arterial calcification

Current pharmaceutical design, 2014-01, Vol.20 (37), p.5853-5861

2014

Volltextzugriff (PDF)

TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis

iScience, 2019-02, Vol.12, p.41-52

2019

Volltextzugriff (PDF)

NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease

Antioxidants, 2017-07, Vol.6 (3), p.56

2017

Volltextzugriff (PDF)

ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes

Journal of cellular biochemistry, 2003-05, Vol.89 (2), p.289-300

2003

Volltextzugriff (PDF)

A Nanoparticle-Based Affinity Sensor that Identifies and Selects Highly Cytokine-Secreting Cells

iScience, 2019-10, Vol.20, p.137-147

2019

Volltextzugriff (PDF)

Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment

Biochemical journal, 2007-10, Vol.407 (1), p.79-87

2007

Volltextzugriff (PDF)

Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

PloS one, 2013-09, Vol.8 (9)

2013

Volltextzugriff (PDF)

Tumour necrosis factor superfamily members in ischaemic vascular diseases

Cardiovascular research, 2019-03, Vol.115 (4), p.713-720

2019

Volltextzugriff (PDF)

A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia

Cellular and molecular life sciences : CMLS, 2023-02, Vol.80 (2), p.44, Article 44

2023

Volltextzugriff (PDF)

On the TRAIL of obesity and diabetes

Trends in endocrinology and metabolism, 2013-11, Vol.24 (11), p.578-587

2013

Volltextzugriff (PDF)

Broad‐spectrum chemokine inhibition blocks inflammation‐induced angiogenesis, but preserves ischemia‐driven angiogenesis

The FASEB journal, 2019-12, Vol.33 (12), p.13423-13434

2019

Volltextzugriff (PDF)

The multiple roles of chemokines in the mechanisms of stent biocompatibility

Cardiovascular research, 2021-09, Vol.117 (11), p.2299-2308

2021

Volltextzugriff (PDF)

Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia

American journal of physiology: endocrinology and metabolism, 2019-08, Vol.317 (2), p.E388-E398

2019

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(10)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The walking dead: macrophage inflammation and death in atherosclerosis

The Prognostic, Diagnostic, and Therapeutic Potential of TRAIL Signalling in Cardiovascular Diseases

Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo

TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro

Sex, Endothelial Cell Functions, and Peripheral Artery Disease

TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL

Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice

TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis

Expression, regulation and function of trail in atherosclerosis

Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: Mechanisms of PDGF-BB-mediated VSMC proliferation and migration

Regulation and function of Rankl in arterial calcification

TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis

NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease

ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes

A Nanoparticle-Based Affinity Sensor that Identifies and Selects Highly Cytokine-Secreting Cells

Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment

Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL

Tumour necrosis factor superfamily members in ischaemic vascular diseases

A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia

On the TRAIL of obesity and diabetes

Broad‐spectrum chemokine inhibition blocks inflammation‐induced angiogenesis, but preserves ischemia‐driven angiogenesis

The multiple roles of chemokines in the mechanisms of stent biocompatibility

Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia

Suchergebnisse filtern